Mitchell Sinkler & Starr Baxter International Inc Transaction History

Mitchell Sinkler & Starr

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$74.57 - $87.19 $272,777 - $318,941	-3,658 Closed	0 $0
Q3 2021 Oct 12, 2021	SELL	$73.77 - $83.61 $19,180 - $21,738	-260 Reduced 6.64%	3,658 $294,000
Q2 2021 Jul 15, 2021	SELL	$80.5 - $88.01 $33,005 - $36,084	-410 Reduced 9.47%	3,918 $315,000
Q4 2020 Feb 09, 2021	SELL	$75.39 - $82.36 $20,732 - $22,649	-275 Reduced 5.97%	4,328 $347,000
Q2 2020 Jul 20, 2020	BUY	$78.66 - $94.14 $44,442 - $53,189	565 Added 13.99%	4,603 $396,000
Q1 2020 Apr 07, 2020	BUY	$71.57 - $93.3 $28,270 - $36,853	395 Added 10.84%	4,038 $328,000
Q3 2019 Nov 06, 2019	SELL	$81.4 - $89.78 $211,640 - $233,428	-2,600 Reduced 41.65%	3,643 $319,000
Q2 2019 Jul 17, 2019	BUY	$73.44 - $82.41 $40,392 - $45,325	550 Added 9.66%	6,243 $511,000
Q1 2019 Apr 08, 2019	BUY	$64.48 - $81.31 $81,244 - $102,450	1,260 Added 28.42%	5,693 $463,000
Q4 2018 Jan 24, 2019	BUY	$61.45 - $77.8 $26,116 - $33,065	425 Added 10.6%	4,433 $292,000
Q2 2018 Jul 11, 2018	BUY	$63.43 - $75.41 $254,227 - $302,243	4,008 New	4,008 $296,000

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

Stay updated on Mitchell Sinkler & Starr with notifications on news.